Arthritis Research & Treatment Center

Stockbridge, Georgia 30281

0 studies enrolling now · 2 studies all time

What they study most

Lupus Erythematosus, Systemic, Refractory Chronic Gout

Studies at this site

• A 52-Week, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study to Evaluate the Efficacy and Safety of a 200-mcg Dose of IPP-201101 Plus Standard of Care in Patients With Systemic Lupus Erythematosus — Completed
• Observational Study of the Use of Pegloticase (KRYSTEXXA®) in Refractory Chronic Gout — Completed